The global cardiac mapping market size is expected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019, at a CAGR of 8.7%. The inclusion of new entrants in the market, growing investments, funds, and grants, increasing incidence of target diseases, and growth in the geriatric population are the key drivers of the cardiac mapping systems market.
Contact cardiac mapping are estimated to account for the largest share of the cardiac mapping systems product market in 2019
The contact cardiac mapping market is segmented into contact cardiac mapping systems and non-contact cardiac mapping systems. The contact cardiac mapping systems segment is divided further into electroanatomical mapping, basket catheter mapping, and traditional endocardial mapping. The contact cardiac mapping systems segment held the largest share of the cardiac mapping systems market in 2019. The advantages offered by contact cardiac mapping systems, such as detection of the precise locations of mapping and ablation catheters in a three-dimensional environment and requirement of just a few beats recordings might uncover the arrhythmia circuit, are the major factors driving the growth of this product segment.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89853405
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac mapping market. These methods were also used extensively to determine the extent of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry and markets have been identified through extensive secondary research
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Atrial fibrillation is the primary application areas of the global cardiac mapping market
The market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias. The atrial fibrillation segment estimated to command the largest share of the market in 2019, and this segment is also projected to register the highest CAGR owing to the rise in incidences of AF worldwide and the subsequent increase in the ablation procedures.
The APAC cardiac mapping market to grow at the highest CAGR during the forecast period
While North America is expected to dominate the global cardiac mapping industry in 2019, the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the large population, increasing geriatric population, the growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, and growing demand for advanced technologies.
Key Players:
The major players operating in the cardiac mapping market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US). The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=89853405
The report “Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region – Global Forecast to 2024″, the Cardiac Mapping System Market is expected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019, at a CAGR of 8.7%.The Growth in the cardiac mapping industry is driven primarily by factors such as new entrants in the market, growing investments, funds, and grants, increasing incidence of target diseases, and growth in the geriatric population.Market Size Estimation;Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac mapping market.
The research methodology used to estimate the market size includes the following:– The key players in the industry and markets have been identified through extensive secondary research– The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes– All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sourcesRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89853405Atrial fibrillation is the primary application areas of the global cardiac mapping marketThe market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias.
The atrial fibrillation segment estimated to command the largest share of the market in 2019, and this segment is also projected to register the highest CAGR owing to the rise in incidences of AF worldwide and the subsequent increase in the ablation procedures.Geographical View in-detailed:North America held the largest share of the market in 2019 and is projected to continue to do so during the forecast period.
Factors such as the increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, growing focus of government organizations on providing funding for research, and increasing geriatric population in Canada are driving the North American cardiac mapping market.Key Market Players;The major vendors in the cardiac mapping market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US).
These leading players offer a strong suit of products for cardiac mapping and have a broad geographic presence.
The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89853405Biosense Webster (US) held the dominant position in the cardiac mapping market in 2018.
Global Cardiac Mapping System Market - A Report by Fact.MRFact.MR, in its latest business intelligence study, depicts the nuts and bolts of the global cardiac mapping system market.
The cardiac mapping system market report presents detailed information regarding the drivers, restraints, opportunities and trends affecting market growth.
Each segment along with its sub-segment is analyzed in terms of value and volume.
Further, the cardiac mapping system market report elaborates the market behavior of each vendor operating in the cardiac mapping system market.The cardiac mapping system market report considers the following years to present the overall market growth:Estimated Year: 2028Forecast Year: 2018 – 2028Key findings of the cardiac mapping system market study:Regional breakdown of the cardiac mapping system market based on predefined taxonomy.Innovative manufacturing processes implemented by cardiac mapping system market vendors in detail.Region-wise and country-wise fragmentation of the cardiac mapping system market to grasp the revenue, and growth outlook in these areas.Changing preferences among consumers across various regions and countries.Factors (Positive and Negative) impacting the growth of the global cardiac mapping system market.On the basis of technology, the cardiac mapping system market study consists of:Cardiac radionuclide imagingRemote Navigation SystemsMagnetic Navigation SystemRobotic Navigation SystemsRequest for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S_id=1131On the basis of end user, the cardiac mapping system market study incorporates:HospitalsClinicsAmbulatory Surgical CentersDiagnosis CentersOn the basis of region, the cardiac mapping system market study contains:North America (U.S., Canada)Latin America (Mexico.
Brazil)Western Europe (Germany, Italy, France, U.K, Spain)Eastern Europe (Poland, Russia)Asia Pacific (India, ASEAN, Australia & New Zealand)ChinaJapanMiddle East and Africa (GCC Countries, S. Africa, Northern Africa)Key players analyzed in the cardiac mapping system market study:Biosense Webster IncBoston Scientific CorporationMedical Computer Systems LtdAbbott LaboratoriesAurora Health CareMedtronic plcGeneral Electric CompanyQueries addressed in the cardiac mapping system market report:Why are the cardiac mapping system market players targeting region for increased product sales?What patented technologies are the players utilizing in the global cardiac mapping system market?Which regions are displaying the fastest growth in the cardiac mapping system market?What are the underlying micro- macroeconomic factors affecting the global cardiac mapping system market?Request TOC of this Report - https://www.factmr.com/connectus/sample?flag=T_id=1131Why choose Fact.MR?Reports published by Fact.MR are a result of the combination of our experts and digital technologies.
We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites.
